PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
01-Apr-2025 Adalimumab, Infliximab and Etanercept Biosimilars Market Size, Share and Future Outlook 2032 Futurewise Research
01-Apr-2025 AEVIS VICTORIA SA - The hotel branch of AEVIS VICTORIA recorded strong growth in 2024, driven by the quality of its assets and the strength of its integrated model. AEVIS VICTORIA SA
01-Apr-2025 Newron presents 2024 financial results and provides 2025 outlook Newron Pharmaceuticals S.p.A.
01-Apr-2025 Lonza Completes its Share Buyback Program Lonza Group AG
01-Apr-2025 DEA’s Marijuana Legal Blunder and Loss: MMJ Serves Up an April Fools ‘Gift’ a Gut Punch LawSuit for Irreparable Harm ACCESS NewsWire
31-Mar-2025 1933 Industries Reports Second Quarter 2025 Financial Results ACCESS NewsWire
31-Mar-2025 Verisante Technology, Inc. Announces Termination of Proposed RTO with SunRegen Healthcare AG ACCESS NewsWire
31-Mar-2025 AAVantgarde and TIGEM Publish Groundbreaking Research in Science Advances AAVantgarde Bio
31-Mar-2025 OKYO Pharma Announces Positive Data in Long-Term Stability of Urcosimod OKYO Pharma
31-Mar-2025 IMFINZI® (durvalumab) approved in the US as first and only perioperative immunotherapy for patients with muscle-invasive bladder cancer AstraZeneca
31-Mar-2025 Lynred launches two Advanced Thermal Imaging (ATI) modules to make cooled infrared sensing easier to use Andrew Lloyd Associates
31-Mar-2025 Healthcare Revenue Cycle Management Market is Expected to Reach ~11–12% CAGR by 2027 Medi-Tech Insights
31-Mar-2025 APONTIS PHARMA with significant sales and earnings increase in 2024 financial year – squeeze-out and merger planned APONTIS PHARMA AG
31-Mar-2025 Glidewell Partners With Digital Arches to Streamline All-on-X Workflows ACCESS NewsWire
31-Mar-2025 Global Animal Health Market Size, Share and Growth is Expand at 8-9% CAGR by 2029 Medi-Tech Insights
31-Mar-2025 Clinical Trials Market Expands at 6-7% CAGR: Driving Breakthroughs in Medical Research Medi-Tech Insights
31-Mar-2025 Pharmacy Automation Market to Expand at 8.5% CAGR | Innovations Reshaping the Industry Medi-Tech Insights
31-Mar-2025 Bioanalytical Services Market Outlook: Set for Double-Digit CAGR Growth by 2027 Medi-Tech Insights
31-Mar-2025 Global Home Healthcare Services Market Set to Grow at ~8–10% CAGR by 2029 Medi-Tech Insights
31-Mar-2025 RYBREVANT®▼ (amivantamab) plus LAZCLUZE®▼ (lazertinib) demonstrates significant overall survival benefit in patients with advanced non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R substitution mutations versus osimertinib Johnson & Johnson